Read by QxMD icon Read

Para revisar

shared collection
10 papers 25 to 100 followers
By Néstor Fernando Salomón
Patrice P Cacoub
No abstract text is available yet for this article.
June 28, 2014: Lancet
Hubert Barennes, Merlin L Willcox, Bertrand Graz, Eric Pussard
No abstract text is available yet for this article.
April 5, 2014: Lancet
Mir Sadat-Ali, Haifa A Al-Turki
No abstract text is available yet for this article.
April 12, 2014: Lancet
Mazda Adli, Ulrich Hegerl
No abstract text is available yet for this article.
April 19, 2014: Lancet
(no author information available yet)
No abstract text is available yet for this article.
April 29, 2014: Circulation
Eve A Kerr, Timothy P Hofer
No abstract text is available yet for this article.
December 10, 2012: Archives of Internal Medicine
Marielle Beerepoot, Gerben Ter Riet, Suzanne E Geerlings
No abstract text is available yet for this article.
November 26, 2012: Archives of Internal Medicine
Chih-Cheng Chang, Hsiao-Chi Chuang, Cheng-Li Lin, Fung-Chang Sung, Yen-Jung Chang, Chung Y Hsu, Ling-Ling Chiang
OBJECTIVE: Patients with sleep apnea syndrome (SAS) carry a higher stroke risk. The differential stroke risk between sex and among different age groups has not yet been specifically addressed in previous studies. METHODS: Using a universal insurance claims database, we identified a large cohort of SAS patients from 1997 to 2010 and assessed the sex- and age-specific stroke risk compared with a control cohort matched for age, sex, and index date. Cox regression analyses were performed to assess the hazard ratio (HR) of stroke and the corresponding 95% confidence interval (CI)...
April 2014: Sleep Medicine
Andrew Davenport, Jawad Ahmad, Ali Al-Khafaji, John A Kellum, Yuri S Genyk, Mitra K Nadim
Hepatorenal syndrome (HRS) is defined as the occurrence of renal dysfunction in a patient with end-stage liver cirrhosis in the absence of another identifiable cause of renal failure. The prognosis of HRS remains poor, with a median survival without liver transplantation of <6 months. However, understanding the pathogenesis of HRS has led to the introduction of treatments designed to increase renal perfusion and mean arterial blood pressure using vasopressors and albumin, which has led to improvement in renal function in ∼50% of patients...
January 2012: Nephrology, Dialysis, Transplantation
Daniel De Backer, Patrick Biston, Jacques Devriendt, Christian Madl, Didier Chochrad, Cesar Aldecoa, Alexandre Brasseur, Pierre Defrance, Philippe Gottignies, Jean-Louis Vincent
BACKGROUND: Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other. METHODS: In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure. When blood pressure could not be maintained with a dose of 20 microg per kilogram of body weight per minute for dopamine or a dose of 0...
March 4, 2010: New England Journal of Medicine
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"